Expanding Clinical Trial Pipeline Fuels Antibody Drug Conjugates Market Growth
The growing number of clinical trials and regulatory approvals is strengthening the development of antibody-drug conjugates. Continued clinical research is helping evaluate new therapies and expand potential treatment applications across oncology.
Market Overview
The Antibody Drug Conjugates Market is projected to reach US$38,077.45 million by 2031 from US$8,105.65 million in 2023,...
